Skip to main content

Table 2 Triage by method, treatment and time elapsed in follow-up of HPV positive women in Nicaragua in 2017

From: HPV-based cervical cancer screening in Nicaragua: from testing to treatment

Ā 

Total Triaged

N (%)

Triaged with Pap N (%)

Triaged with VIA N (%)

P valueā€”

Women triaged

3656 (100)

2784 (100)

872 (100)

<ā€‰0.001

Triage result

ā€ƒNegative

2293 (62.7)

1851 (66.6)

442 (50.7)

<ā€‰0.001

ā€ƒPositivea

915 (25.0)

513 (21.7)

402 (46.1)

<ā€‰0.001

ā€ƒUnknown

448 (12.3)

420 (15.1)

28 (3.2)

<ā€‰0.001

Treated

486 (13.3)

132 (4.7)b

361 (41.4)

<ā€‰0.001

Percent treated among triage-positive women

53.1

25.7

89.8

Ā 

Number of days from screening to triage

N (women with available data)

2566 (70.2)

2089

477

Ā 

Mean (SD)

61.9 (SD: 43.8)

58.1 (SD: 37.7)

78.6 (SD: 61.5)

<ā€‰0.001

Number of days from triage to treatment

N (women with available data)

470 (51.3c)

116

318

Ā 

Treated on same day

263 (56.0)

2 (1.7)

262 (82.4)

<ā€‰0.01

Mean days if not treated on same day (SD)

89.2 (SD 86.5)

103.8 (SD 93.4)

75.2 (SD 83.6)

0.05

  1. Abbreviations: VIA visual inspection with acetic acid, SD standard deviation
  2. aA Pap result of atypical squamous cells of undetermined significance (ASCUS) or greater in the triage step was considered triage-positive and therefore required treatment according to the local management algorithm
  3. bThere were 82 cases classified as high-grade squamous intraepithelial (HSIL) in Pap triage, of which 25 were treated (30.5%)
  4. cPercentage of triage-positive women with available data
  5. ā€”P-value comparing HPV positive women triaged with Pap versus VIA